Delek US (NYSE:DK) EVP Sells $504,590.40 in Stock

Key Points

  • Delek US EVP Robert Wright sold 10,720 shares on May 13 at an average price of $47.07, for total proceeds of about $504,590. After the sale, he still held 48,148 shares.
  • The company recently posted better-than-expected quarterly results, reporting EPS of $0.08 versus analysts’ توقعation of a loss, and revenue of $2.65 billion versus $2.33 billion expected.
  • Delek US also paid a quarterly dividend of $0.255 per share, equivalent to $1.02 annually and a yield of about 2.3%, while analysts currently rate the stock a consensus Hold with a $44.23 price target.

Delek US Holdings, Inc. (NYSE:DK - Get Free Report) EVP Robert Wright sold 10,720 shares of the business's stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $47.07, for a total transaction of $504,590.40. Following the sale, the executive vice president directly owned 48,148 shares of the company's stock, valued at approximately $2,266,326.36. The trade was a 18.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Delek US Trading Up 2.5%

Shares of DK stock opened at $44.79 on Friday. Delek US Holdings, Inc. has a 1 year low of $17.56 and a 1 year high of $49.50. The firm has a fifty day moving average price of $43.21 and a 200-day moving average price of $37.39. The company has a debt-to-equity ratio of 10.51, a current ratio of 0.76 and a quick ratio of 0.49. The company has a market cap of $2.75 billion, a price-to-earnings ratio of -49.22, a PEG ratio of 0.37 and a beta of 0.63.

Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.42) by $1.50. Delek US had a negative net margin of 0.48% and a positive return on equity of 22.90%. The firm had revenue of $2.65 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the firm posted ($2.32) EPS. The company's revenue for the quarter was up .4% compared to the same quarter last year. As a group, equities analysts predict that Delek US Holdings, Inc. will post 3.99 earnings per share for the current year.

Delek US Announces Dividend




The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Friday, May 1st were given a dividend of $0.255 per share. The ex-dividend date of this dividend was Friday, May 1st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 2.3%. Delek US's payout ratio is presently -112.09%.

Analyst Ratings Changes

DK has been the topic of a number of analyst reports. Wells Fargo & Company lifted their target price on shares of Delek US from $54.00 to $59.00 and gave the company an "overweight" rating in a research note on Tuesday, March 31st. Weiss Ratings cut shares of Delek US from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday. Zacks Research upgraded shares of Delek US from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, April 29th. TD Cowen lowered their target price on shares of Delek US from $60.00 to $44.00 and set a "hold" rating on the stock in a research note on Monday, April 27th. Finally, Wall Street Zen cut shares of Delek US from a "strong-buy" rating to a "buy" rating in a research note on Sunday, May 10th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $44.23.

Read Our Latest Stock Analysis on Delek US

Institutional Trading of Delek US

Several hedge funds have recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Delek US by 19.0% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,136,720 shares of the oil and gas company's stock worth $51,232,000 after purchasing an additional 181,820 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Delek US by 26.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,596,093 shares of the oil and gas company's stock worth $71,936,000 after purchasing an additional 335,892 shares in the last quarter. Caxton Associates LLP lifted its stake in Delek US by 240.4% in the 1st quarter. Caxton Associates LLP now owns 38,638 shares of the oil and gas company's stock worth $1,741,000 after purchasing an additional 27,288 shares in the last quarter. Sei Investments Co. lifted its stake in Delek US by 85.4% in the 1st quarter. Sei Investments Co. now owns 102,365 shares of the oil and gas company's stock worth $4,614,000 after purchasing an additional 47,159 shares in the last quarter. Finally, Hillsdale Investment Management Inc. lifted its stake in Delek US by 60.1% in the 1st quarter. Hillsdale Investment Management Inc. now owns 215,390 shares of the oil and gas company's stock worth $9,708,000 after purchasing an additional 80,850 shares in the last quarter. Hedge funds and other institutional investors own 97.01% of the company's stock.

Delek US Company Profile

(Get Free Report)

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.

Recommended Stories

Insider Buying and Selling by Quarter for Delek US (NYSE:DK)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Delek US?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Delek US and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles